Journal
JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS
Volume 24, Issue 7, Pages E62-E78Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.5435/JAAOS-D-16-00086
Keywords
-
Categories
Funding
- Arthrex
- Ossur
- Smith Nephew
- ConMed Linvatec
- Aesculap/B. Braun Medical
- Aperion Biologics
- Becton Dickinson
- DePuy Synthes
- Genzyme
- Moximed
- RNL Bio
Ask authors/readers for more resources
Strategies that seek to enhance musculoskeletal tissue regeneration and repair by modulating the biologic microenvironment at the site of injury have copsiderable therapeutic potential. Current and emerging biologic approaches include the use of growth factors, platelet-rich plasma, stem cell therapy, and scaffolds,The American Academy of Orthopaedic Surgeons hosted a research symposium in November 2015 to review the current state-of-the-art biologic treatments of articular cartilage, muscle, tendon; and bone injuries and identify knowledge gaps related to these emerging treatments This review outlines the findings of the symposium and summarizes the, consensus reached on how best to advance research on biologic treatment of orthopaedic injuries.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available